Curis, Inc. (LS:A3ETJD) Financings
Financings
| Raise | Date |
|---|---|
| Private placement of shares of common stock (or pre-funded warrants) and accompanying common warrants Announced: about US$8.5M · US$0.51 a share · ½ warrant at US$0.6 for 66 months · A.G.P./Alliance Global Partners +1 Dealers: A.G.P./Alliance Global Partners (lead), Laidlaw & Company (UK) Ltd. Use of proceeds: Research and development, working capital and general corporate purposes | Oct 16, 2026 |
| Public offering of common stock (or pre-funded warrants) and accompanying common warrants Announced: about US$5.6M · US$1.5 a share · Warrants at US$1.75 for 60 months · A.G.P./Alliance Global Partners +1 Dealers: A.G.P./Alliance Global Partners (lead), Laidlaw & Company (UK) Ltd. Use of proceeds: Fund research and development activities, working capital and general corporate purposes | Aug 13, 2026 |
| Private placement of private placement (PIPE financing) Closed: US$20.2M raised · US$1,000 a share · Warrants at US$0.75 · Laidlaw & Company (UK) Ltd. Dealers: Laidlaw & Company (UK) Ltd. (lead) Buyers: Nantahala Capital; Stonepine Capital Management; Pointillist Partners, LLC; The Red Hook Fund, LP Insiders: Members of the Company's management team and board of directors participated. Use of proceeds: Research and development, general corporate expenses and working capital | Jan 9, 2026 |
| Registered direct offering of common stock, with concurrent private placement of pre-funded and common warrants Announced: about US$7M · US$2.275 a share · Warrants at US$2.15 for 60 months · Laidlaw & Company (U.K.) Ltd. +1 Dealers: Laidlaw & Company (U.K.) Ltd., Jones Use of proceeds: Research, development, working capital and other general corporate purposes | Jul 2, 2025 |
| Registered direct offering of common stock, with concurrent private placement Closed: US$8.8M raised Use of proceeds: To fund planned operations into the fourth quarter of 2025 | May 6, 2025 |